The Transcatheter Closure of Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants: Technique and Results

J Cardiovasc Dev Dis. 2023 Nov 27;10(12):476. doi: 10.3390/jcdd10120476.
Alban-Elouen Baruteau  1   2   3   4 Alain Fraisse  5   6 Gianfranco Butera  7 Carles Bautista-Rodriguez  5   6

PMID: 38132644 PMCID: PMC10744056 DOI: 10.3390/jcdd10120476


Persistent patent ductus arteriosus is a very common condition in preterm infants. Although there is no management agreed by consensus, despite numerous randomized controlled trials, hemodynamically significant patent ductus arteriosus increases morbidity and mortality in these vulnerable patients. Medical treatment is usually offered as first-line therapy, although it carries a limited success rate and potential severe adverse events. In recent years, transcatheter patent ductus arteriosus closure has fast developed and become widely accepted as a safe and efficient alternative to surgical ductal ligation in extremely low birth weight infants >700 g, using most often the dedicated Amplatzer Piccolo Occluder device. This article aims to provide an appraisal of the patients’ selection process, and a step-by-step description of the procedure as well as a comprehensive review of its outcomes.

Keywords: Doppler echocardiography; extremely low-birth-weight infants; outcomes; patent ductus arteriosus; premature infant.

Lire plus